Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications adjuvant therapy sparing rectal cancer achieving complete response after chemoradiation
… Agency (EMA) and US Food and Drug Administration (FDA) for cancer treatment found that the agencies use different … hosted by study authors and based on PRO labeling of cancer treatment drugs, focuses on key differences between … sponsors face when including PRO-related endpoints in cancer clinical research? And how can these challenges be …
RTI and Nested Knowledge Announce Collaboration to Enhance Life Science and Healthcare Research Share on: April 24, 2024 Strategic collaboration follows RTI’s equity investment in advanced tech-enabled research services RESEARCH TRIANGLE PARK, N.C. — RTI …
… and Biological Products Share on: October 10, 2023 In response to the 21st Century Cures Act, which aims to …
… About one-third of patients with ADHD have an inadequate response to initial stimulant treatment and consequently … in children and adolescents who have had an inadequate response to the currently recommended first-line stimulant … Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate published last week, found that …
Stephanie Earnshaw Honored with NC State University Distinguished Alumnus Award Share on: December 8, 2022 Congratulations to Dr. Stephanie Earnshaw, PhD, Senior Vice President, Health Economics at RTI Health Solutions (RTI-HS) on being named a North …
Betsy Falvey Project and Proposal Office Headquarters - Research Triangle Park, North Carolina, USA BA, Business Management North Carolina State University, Raleigh, NC Betsy Falvey is a Senior Project Manager in Project and Proposal Operations at …
… stop by our posters and see our research on Avelumab therapy and Fetal and neonatal alloimmune thrombocytopenia. … CT April 16, 2024 Avelumab first-line maintenance (1LM) therapy for locally advanced/metastatic urothelial carcinoma …
… example, if we suspect a drug has a rare toxicity after years of being marketed, we may resort to analyzing …
… areas including addiction, ophthalmology, pain, cancer, diabetes, schizophrenia, lupus, HIV, hepatitis, … and implementing global HEOR strategy for launching a new therapy for opioid use disorder. …
… patients (pts) with de novo, HR+/HER2− metastatic breast cancer: a SEER-Medicare analysis. Brufsky A, Sandin R, … Session Type and Title: Poster Session – Breast Cancer—Metastatic Session Date and Time: 6/2/2024 9:00 …